Genfit S.A. (EPA:GNFT)
France flag France · Delayed Price · Currency is EUR
9.10
-0.34 (-3.60%)
Oct 2, 2026, 5:35 PM CET

Genfit Revenue

Genfit had revenue of 25.03M EUR in the half year ending June 30, 2026, a decrease of -59.10%. This brings the company's revenue in the last twelve months to 60.48M, up 33.18% year-over-year. In the year 2025, Genfit had annual revenue of 71.12M with 0.25% growth.

Revenue (ttm)
60.48M
Revenue Growth
+33.18%
P/S Ratio
7.56
Revenue / Employee
373.96K
Employees
161
Market Cap
455.22M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202571.12M177.00K0.25%
Dec 31, 202470.94M32.76M85.83%
Dec 31, 202338.18M11.61M43.70%
Dec 31, 202226.57M-59.01M-68.96%
Dec 31, 202185.58M77.82M1,003.11%
Dec 31, 20207.76M-33.20M-81.06%
Dec 31, 201940.96M33.47M446.58%
Dec 31, 20187.49M639.00K9.32%
Dec 31, 20176.86M72.00K1.06%
Dec 31, 20166.78M2.43M55.64%
Dec 31, 20154.36M-2.42M-35.68%
Dec 31, 20146.78M808.40K13.55%
Dec 31, 20135.97M-42.90K-0.71%
Dec 31, 20126.01M-768.20K-11.33%
Dec 31, 20116.78M1.73M34.35%
Dec 31, 20105.05M-5.79M-53.43%
Dec 31, 200910.83M-9.08M-45.60%
Dec 31, 200819.91M-296.57K-1.47%
Dec 31, 200720.21M8.79M76.95%
Dec 31, 200611.42M-1.77M-13.43%
Dec 31, 200513.19M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Valneva SE142.94M
Cellectis55.86M
MedinCell24.28M
Nanobiotix11.51M
Innate Pharma9.81M
Sensorion6.16M
Transgene5.62M
DBV Technologies4.41M
Revenue Rankings